InsidersTradesSigma
Follow the OncoZenge AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, OncoZenge AB has recorded 8 reports. Market capitalisation: €83.6m. The latest transaction was filed on 7 September 2026 (Purchase). Among the most active insiders: Stian Kildal. Every trade is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€131,378
8 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate OncoZenge AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 7.60.
47Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 September 2026
Declarations8 total
1,000,000 shares@ SEK 0.207TeckningsoptionFI:csv-7fec5a8a7cc35f704a73
1,000,000 shares@ SEK 0.207TeckningsoptionFI:csv-2661306bb9c361952e04
20,000 shares@ SEK 5.050.12% mcap51.4% of flowAktieISIN SE0015504097FI:csv-3669c09e81f729583754
18,000 shares@ SEK 5.300.096% mcap100.0% of flowAktieISIN SE0015504097FI:csv-e1e9e5c0bdfb135d51c9
74,999 shares@ €0.48210.41% mcap76.8% of flowAktieISIN SE0015504097FI:A003U252-1
25,000 shares@ €0.57330.16% mcap100.0% of flowAktieISIN SE0015504097FI:A003S148-1
20,000 shares@ €0.54740.12% mcap23.2% of flowAktieISIN SE0015504097FI:A003N025-2
15,000 shares@ SEK 10.25100.0% of flowBTA (betald tecknad aktie)ISIN SE0015531231FI:A001R016-1
8 of 8 declarations
Acerca de OncoZenge AB
OncoZenge AB es una empresa enfocada en el desarrollo de tratamientos innovadores contra el cáncer. Cotiza en la bolsa de valores XSTO.